A biological preparation known as a vaccination offers active acquired protection to a specific infectious disease. A vaccination often comprises a substance that resembles a germ that causes a disease, this substance is frequently created from a bacteria's weaker or dead forms, its toxins, or one of its surface proteins.

Data Bridge Market Research analyses that the travel vaccine market which was USD 3.2 billion in 2021, would rocket up to USD 7.70 billion by 2029, and is expected to undergo a CAGR of 11.6% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

To achieve robust business growth, companies must embrace the indispensable service of market research reports in today's rapidly evolving marketplace. The Travel Vaccine report, brimming with the latest market insights and analyses, serves as a beacon, bringing clarity to the marketplace. This comprehensive market research study scrutinizes various facets, including market status, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, and distributor networks. Moreover, the Travel Vaccine market report casts a spotlight on pivotal market dynamics, the current market landscape, and future prospects within the Travel Vaccine industry. Crafted through a harmonious blend of industry acumen, innovative solutions, practical expertise, and cutting-edge technology to elevate user experiences.

Get a Sample Research Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-travel-vaccine-market

Key Growth Drivers:

  • Increase in cases of flu

The flu part for the most comprehensive travel vaccine business serving is estimated based on the target virus. That was largely attributable to the enormous number of cases of influenza that were accounted for throughout the forecast period and the segment will continue to control the market.

  • Increase in costs for vaccination

Travel-related viruses like hepatitis, tetanus, Japanese encephalitis, meningitis, and yellow fever are becoming more widespread all over the world. This would significantly increase the costs associated with the development of more effective vaccinations, opening up new market opportunities for travel vaccines throughout the forecast period of 2022 to 2029.

  • Rising number of vaccines

Global arrivals of foreign visitors surged from 1.0 billion in 2012 to about 1.4 billion in 2018. Many of these tourists travel from rich nations to places where endemic diseases are prevalent. The need for vaccines will rise as more individuals travel to nations where certain diseases are widespread.

The report outlines the involvement of key players, including:

GSK plc (U.K.), Sanofi (France), Merck KGaA (Germany), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Bavarian Nordic (Denmark), Janssen Pharmaceuticals Inc. (U.S.), CSL Limited (Australia), AstraZeneca (U.K.), Altimmune (U.K.), Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Crucell (Netherlands)

Key Market Segmentation

Composition (Mono Vaccines, Combination Vaccines), Disease (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, Others)

The Travel Vaccine market report includes the following countries in different regions:

The regions mentioned above encompass a comprehensive coverage of key markets, offering a global perspective on the market landscape. Here's an overview of the regions and the countries they include:

  1. North America: United States, Canada, and Mexico.
  2. Europe: Germany, France, United Kingdom, Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, and other European countries.
  3. Asia-Pacific (APAC): China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, and other Asia-Pacific countries.
  4. Middle East and Africa (MEA): Saudi Arabia, United Arab Emirates (U.A.E), South Africa, Egypt, Israel, and other countries in the Middle East and Africa region.
  5. South America: Brazil, Argentina, and other countries in South America.

 

Know More about This Premium Research Report @ https://www.databridgemarketresearch.com/reports/global-travel-vaccine-market

Browse More Reports:

https://www.databridgemarketresearch.com/reports/global-icu-devices-market

https://www.databridgemarketresearch.com/reports/global-ultramicrotome-market

https://www.databridgemarketresearch.com/reports/global-cryochambers-market

https://www.databridgemarketresearch.com/reports/global-monoclonal-antibodies-market

https://www.databridgemarketresearch.com/reports/global-tularemia-therapeutics-market

https://www.databridgemarketresearch.com/reports/global-pancreatitis-market

About Data Bridge Market Research, Private Ltd

Data Bridge Market Research is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe.

Contact Us

US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – corporatesales@databridgemarketresearch.com